Funding for this research was provided by:
Gouvernement du Canada | Instituts de Recherche en Santé du Canada | CIHR Skin Research Training Centre (113524)
Pierre Theroux Family Foundation for Alzheimer’s Disease Research Maisonneuve-Rosemont Hospital Foundation
Article History
Received: 30 December 2019
Accepted: 3 March 2021
First Online: 23 March 2021
Competing interests
: A. F. and G. B. are co-founders and shareholders of StemAxon<sup>TM</sup>. The corporation was however not involved in this study. R. H. and A. B. declare no competing interests.